Latest news
Sarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 12:29:45 GMTSarepta taps AbbVie, Tessera vet Severino to write Duchenne firm's next chapter - Fierce PharmaFierce Pharma · Mon, 27 Jul 2026 07:00:00 GMT